ESA 5000IU Injection: Erythropoiesis-Stimulating Agent for Medical Use

ESA 5000IU Injection

Active components: Recombinant human erythropoietin alfa/epoetin alfa.

Class of drugs: Erythropoiesis-stimulating agents (ESAs).

Uses:

• Chronic kidney disease (CKD);
• Cancer chemotherapy;
• HIV infection treatment with zidovudine;
• Reducing the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures.

Contraindications:

• Hypersensitivity to the drug or its components;
• Uncontrolled hypertension;
• Active thrombotic microangiopathy (TMA);
• Pure red cell aplasia (PRCA);
• Uncontrolled seizures;
• Pregnancy;
• Lactation;
• Caution in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer;
• Not recommended for children under 18 unless the benefits outweigh the risks;
• Close monitoring of older adults for side effects.

Interaction with other drugs: Inform your doctor about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with ESA 5000IU Injection, reducing effectiveness or causing undesirable side effects.

Storage:

• Store at room temperature, between 2°C to 8°C;
• Keep away from moisture, heat, and light;
• Do not freeze;
• Keep away from children and pets.

Administration:

• Given by subcutaneous injection (under the skin);
• Usually injected in the abdomen, thigh, or upper arm.

Safety advice:

• Pregnancy: consult your doctor about the risks and benefits;
• Breastfeeding: the safety during breastfeeding is not well established, consult a healthcare provider;
• Lung conditions: consult your healthcare provider before taking the medication;
• Liver disease: consult your doctor about the risks and benefits;
• Avoid alcohol as it can increase the risk of side effects;
• Do not drive after receiving the injection as it can cause drowsiness and dizziness.

Side effects:

• Serious: blood clots, stroke, heart attack, death, high blood pressure, seizures, tumor growth, allergic reactions, kidney problems, liver problems, bone marrow problems;
• Common: headache, nausea, vomiting, diarrhea, muscle cramps, pain at the injection site, redness, swelling, or itching at the injection site, fatigue, dizziness, chills, fever.

Word of advice:

• Tell your doctor about all your medical conditions;
• Monitor your blood pressure regularly;
• Get regular blood tests to monitor your red blood cell count and other blood levels;
• Do not self-inject;
• Report any side effects to your doctor immediately;
• Be careful when getting up from a sitting or lying position to avoid dizziness;
• Drink plenty of fluids to help prevent dehydration, which can increase your risk of blood clots.

FAQs:

1. What happens if I miss a dose of ESA 5000IU Injection? Contact your doctor as soon as possible. They will advise you on whether you need to take a double dose.

2. How long does it take for ESA 5000IU Injection to work? It usually takes about 2–4 weeks. However, the time it takes for the medication to work can vary depending on the patient's circumstances.

3. Can I get ESA 5000IU Injection over the counter? No, ESA 5000IU Injection is a prescription medication and cannot be purchased over the counter.

4. What is the dosage of ESA 5000IU Injection? The dosage will vary depending on your individual circumstances. Your doctor will determine the appropriate dosage.

5. What are the most common side effects of ESA 5000IU Injection? The most common side effects are headache, nausea, vomiting, diarrhea, muscle cramps, pain at the injection site, and redness, swelling, or itching at the injection site. Serious side effects, such as blood clots, stroke, heart attack, and death, can also occur.

6. What should I do if I have a leftover ESA 5000IU Injection? Return it to your doctor or pharmacist. Do not throw it away in the trash.

Fact Box:

• Molecule name: Recombinant human erythropoietin alfa/epoetin alfa;
• Therapeutic class: Erythropoiesis-stimulating agents (ESAs);
• Pharmacological class: Erythropoiesis-stimulating agents (ESAs);
• Indications: chronic kidney disease (CKD), cancer chemotherapy, HIV infection treatment with zidovudine.

Tags: injection, vitamin_d, esа, medical_product, health_supplement